REGENXBIO Inc. (RGNX) Revenue History
REGENXBIO Inc. (RGNX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $4.59M |
| 2017-12-31 | $10.39M |
| 2018-12-31 | $218.50M |
| 2019-12-31 | $35.23M |
| 2020-12-31 | $154.57M |
| 2021-12-31 | $470.35M |
| 2022-12-31 | $112.72M |
| 2023-12-31 | $90.24M |
| 2024-12-31 | $83.33M |
| 2025-12-31 | $170.44M |
How RGNX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | $218.71M |
| SPRO | Spero Therapeutics Inc. | $66.80M |
| NKTR | Nektar Therapeutics | $55.23M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
These are five companies in the same sector as RGNX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get REGENXBIO Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("RGNX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RGNX | $9.30 | -0.85% | 0.03M |
| 3 | ||||
| 4 | ||||
| 5 |